Regan Mills, who holds the title President, Product Test at Teradyne (NASDAQ:TER), disclosed a sale of 788 shares of common stock on February 25, 2026. The shares were sold at $332.87 apiece, producing proceeds of $262,301, according to a Form 4 submitted to the Securities and Exchange Commission.
The filing states the disposition was made under a sales plan that Mills adopted on November 25, 2025, structured to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. After the sale, Mills is reported to directly own 11,889.3452 shares of Teradyne.
Market context included in the disclosure notes that Teradyne’s stock has climbed 207% over the previous 12 months. At the time of the report, shares were trading at $320 and the company carried a market capitalization of $50.34 billion.
Analyst activity following Teradyne’s recent earnings
Several brokerages updated their views after Teradyne released quarterly results. Cantor Fitzgerald raised its price target on Teradyne to $330 from $270 and highlighted what it called a pronounced transformation in the company’s business toward artificial intelligence, which the firm says accounted for more than 60% of total revenues in the fourth quarter of 2025.
Morgan Stanley revised its fiscal 2026 and 2027 estimates, citing stronger networking growth forecasts, and increased its price target to $306 from $288. Stifel moved its target to $325 from $280 and kept a Buy rating, pointing to momentum in AI applications within Teradyne’s semiconductor test business. In contrast, Northland lowered its rating to Market Perform, raising valuation concerns despite the company’s strong quarterly results and guidance.
Separately in coverage notes, Cantor Fitzgerald reiterated an Overweight rating and was recorded as maintaining a $270 price target while also characterizing Teradyne’s earnings as a "significant beat and raise."
What the filing shows
The Form 4 filing documents the transaction mechanics and post-sale ownership. The disclosed sale was executed under a pre-established plan adopted on November 25, 2025, intended to meet the conditions of Rule 10b5-1. The filing confirms the sale amount, the per-share price, and Mills’ remaining direct holdings.
Beyond the transaction specifics, the broader public information included in the filing paints a picture of a company experiencing a pronounced shift in revenue composition and receiving mixed responses from sell-side analysts following its quarterly disclosures.
Bottom line
The insider sale by Regan Mills was carried out under a pre-existing trading plan and was disclosed via the required SEC filing. The move occurred against a backdrop of strong share-price appreciation over the past year and a flurry of analyst updates that reflect changing perceptions of Teradyne’s revenue mix and growth drivers, particularly in AI and networking.